When allergic contact dermatitis affects anatomically sensitive sites — the eyelids, face, flexural surfaces, or anogenital region — the inherent thinness of skin in these areas shapes the entire treatment approach.
Lesions located on thinner-skin sites require particular caution. Flexural surfaces, eyelids, the face, and the anogenital region are significantly more susceptible to adverse effects from certain topical therapies, and this anatomical vulnerability must guide agent selection.
On areas with thinner skin (e.g., flexural surfaces, eyelids, face, anogenital region), lower-potency steroids, such as desonide ointment (Desowen), can be helpful and minimize the risk of skin atrophy.
View source ↗